Connection
Jesse Schold to Recombinant Fusion Proteins
This is a "connection" page, showing publications Jesse Schold has written about Recombinant Fusion Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.456 |
|
|
|
-
Schold JD. The burden of proof in the design of early phase clinical trials. Am J Transplant. 2013 Jul; 13(7):1631-2.
Score: 0.344
-
Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation. J Am Soc Nephrol. 2017 Jul; 28(7):2188-2200.
Score: 0.111